A Platform Promoting Inter-Physician Interaction to Support the Management of Adverse Drug Reactions for CLL Patients.

Adverse Drug Reactions (ADRs) cause significant impact for patients' Quality of Life (QoL) and vastly increase costs, especially regarding chronic diseases. To this end, we propose a platform that aims at supporting the management of patients with Chronic Lymphocytic Leukemia (CLL), via an eHealth platform facilitating inter-physician interaction and the provision of treatment consultation by a specialized ADR management team comprised of CLL experts.